Botanical Solution Inc. Announces Closing of Series A Funding
Botanical Solution Inc. (BSI) announced it has closed another $7.6 million financing, as part of Series A, that will fund the commencement of in-house production of QS-21, pharmaceutical grade vaccine adjuvant. Using cost-effective and scalable proprietary methods, BSI will expand QS-21 use in broader vaccine applications. Mr. Salinas made the announcement at Harvard University’s Global […]
